Načítá se...
Donepezil for dementia due to Alzheimer's disease
BACKGROUND: Alzheimer's disease is the most common cause of dementia in older people. One approach to symptomatic treatment of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by blocking the action of the enzyme responsible for the breakdown of the neurotransmi...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513124/ https://ncbi.nlm.nih.gov/pubmed/29923184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001190.pub3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|